Real-World Rates of In-hospital and Postdischarge Deep-Vein Thrombosis and Pulmonary Embolism in At-Risk Medical Patients in the United States

Clinical and Applied Thrombosis/Hemostasis - Tập 17 Số 6 - Trang 611-619 - 2011
Alpesh Amin1, Jay Lin2, Stephen Thompson3, Daniel Wiederkehr4
1School of Medicine, University of California-Irvine, Irvine, CA 92868, USA. [email protected]
2Bruce Wong & Associates, Inc, Radnor, Pennsylvania, PA, USA
3Sanofi-Aventis, Bridgewater, NJ, USA
4Quintiles Consulting, Hawthorne, New York, NY, USA

Tóm tắt

Hospitalized medical patients are at risk of deep-vein thrombosis (DVT) and pulmonary embolism (PE). We evaluated inpatient and postdischarge DVT/PE and thromboprophylaxis rates in US medical patients, using patient admissions from January 2005 to November 2007 in the Premier Perspective™-i3 Pharma Informatics database. Among 15 721 patients with cancer, congestive heart failure, severe lung disease, and infectious disease, 39.0% received inpatient thromboprophylaxis, with the highest rate in patients with cancer (51.9%). In all, 3.4% received outpatient pharmacological prophylaxis. Mean ± SD prophylaxis duration was 2.2 ± 5.7 days. Overall, 3.0% of inpatients had symptomatic DVT/PE, and an additional 1.1% of patients were rehospitalized for DVT/PE or treated in the outpatient setting. Patients with infectious disease had the highest rate of DVT/PE (4.6%). Inpatient DVT/PE and prophylaxis rates of the different medical conditions had a negative correlation ( R 2 = 0.72). This analysis demonstrates the burden of DVT/PE and highlights the underuse of thromboprophylaxis across the continuum of care.

Từ khóa


Tài liệu tham khảo

10.1378/chest.08-0656

10.1001/archinte.162.11.1245

Spyropoulos AC, 2009, Thromb Haemost, 102, 951

10.1001/archinte.167.14.1471

10.1056/NEJM199909093411103

10.1161/01.CIR.0000138928.83266.24

10.1136/bmj.38733.466748.7C

8 HCUP NIS Related Reports. Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality, Rockville, MD. September 2008. http://www.hcup-us.ahrq.gov/db/nation/nis/nisrelatedreports.jsp. Accessed July 27, 2010

10.1378/chest.06-2993

10.1378/chest.07-0430

10.1002/jhm.526

10.1007/s11239-009-0361-z

10.1160/TH09-09-0667

US Department of Health & Human Services. Centers for Medicare & Medicaid Services. Reporting Hospital Quality Data for Annual Payment Update. http://www.cms.hhs.gov/HospitalQualityInits/08_HospitalRHQDAPU.asp. Accessed July 27, 2010

The Joint Commission. Performance Measurement Initiatives. Venous Thromboembolism (VTE) Core Measures Set–Last Updated 4/2009. http://www.jointcommission.org/Performance-Measurement/PerformanceMeasurement/VTE.htm. Accessed July 27, 2010

10.1378/chest.118.6.1680

McGarry LJ, 2004, Am J Manag Care, 10, 632

10.1001/archinte.164.9.963

10.1002/jhm.137

10.1111/j.1538-7836.2009.03509.x

10.1097/01.sla.0000154120.96169.99

10.2146/ajhp070598

10.3810/hp.2010.06.311

US Census Bureau. 2008 American Community Survey (ACS) 1-Year Estimates. http://www.census.gov/acs/www/. Accessed July 27, 2010

10.1016/j.thromres.2010.03.009

10.1016/S1553-7250(09)35052-7

10.1097/MLR.0b013e3181b58940

Thông tin
Thông tin xuất bản

Clinical and Applied Thrombosis/Hemostasis

Tập 17 Số 6

611-619

Thông tin tác giả